Filament is working on a medical-grade version of ayahuasca containing standardized, measurable amounts of its active ingredients. Lightburn hopes that this will open the doors for clinical trials on ayahuasca to be conducted, and they are working on FDA-approved trials for 2023.
The rise of the pot parent makes sense. Today's parents grew up skeptical of drug-war…
The data shows that approximately 4.4% of 8 million urine-based drug tests in the workplace…
Except the science keeps saying it isn't simple at all. The THC percentage is a…
New aggregated polls reveal that 55% of respondents believe marijuana is not dangerous, and a…
Every Croptober, growers waste time on folklore instead of physics. We break down the science…
Leafly's 2026 cannabis voter guide for the midterms is the only plan you need to…